iodoxamate meglumine

iodoxamate meglumine (CHOLOVUE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

CHOLOVUE is a marketed brand name for iodoxamate meglumine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

iodoxamate meglumine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.